- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04860310
Panoramic Presentation and Tolerance Mechanism of Human Endometrium Based on Tiangui Theory
Detailed Description:In the process of women's menstrual cycle, there are different physiology at different time points in a cycle.
Change, investigators select women with a menstrual cycle of 28 days and take samples every 3 days.
Day 4, Day 7, Day 10, Day 13, Day 16, Day 19, Day 22, Day 25, Day 28 days, a total of 10 time points, 20 healthy women were selected, and the transcription, Protein and phosphorylation proteomics, systematically integrated analysis; at the same time, 20 subjects were classified by age group Divide into 4 groups, 21-year-old group, 28-year-old group, 35-year-old group, and 42-year-old group. At the same time, investigators then analyze the differences in the receptivity of the endometrium of different ages.
The experimental design groups are: 21-year-old group, 28-year-old group, 35-year-old group, 42-year-old group, Each group includes D1 group Vs D4 group Vs D7 group Vs D10 group Vs D13 group Vs D16 group Vs D19 group Vs D22 group Vs D25 group Vs D28 group; in phosphorylation modification omics, different time points are compared with each other, Look for transcripts, proteins and phosphorylated proteins that change significantly during the cycle of change. Analyze phosphorylation modification An important role for changing proteins and an important role for cycle changes.
The experiment quantified the proteome and protein acylation modification through TMT (Tandem Mass Tag), and passed GO, KEGG Pathway, Localization, Functional enrichment analysis, Cluster analysis Bioinformatics analysis
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Heilongjiang
-
Harbin, Heilongjiang, China, 150040
- Department of Obstetrics and Gynecology,First Affliated Hospital,Heilongjiang University of Chinese Medicine .
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- The subject's infertility factors are only male factors and/or fallopian tube factors;
- Age: 21/28/35/42/49 years old (calculated according to the birthday month of the Gregorian calendar, no more than 6 months before and after);
- Body mass index (weight/height square)=23~25kg/m2;
- The menstrual cycle is 28+/-1 days (that is, the menstruation is 2-3 days in advance of each month), and the consistency of the past 6 consecutive months (not more than 1 day before and after, that is, 27-29 days);
- Women with a history of pregnancy are preferred;
- Asexual life during the study period;
- No IUD is placed in the uterine cavity;
- Volunteer to participate in the experiment and sign the informed consent form.
Exclusion criteria:
- Women who have a history of miscarriage;
- Women during pregnancy and breastfeeding;
- Mentally ill;
- Those who have had oral contraceptives or hormonal drugs in the past three months;
- Combined with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system;
- Subjects who have participated in other drug clinical trials within six months;
- Those who have poor compliance and the investigator thinks it is inappropriate to participate in this clinical trial.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
21 years old group
|
Subjects need to collect 5ml whole blood (EDTA or heparin anticoagulant) once in the morning on an empty stomach.
Endometrial tissue samples were taken during a complete 28-day menstrual cycle, a total of 6 times, and blood was taken to measure the level of gonadal hormones before each sampling.
|
28 years old group
|
Subjects need to collect 5ml whole blood (EDTA or heparin anticoagulant) once in the morning on an empty stomach.
Endometrial tissue samples were taken during a complete 28-day menstrual cycle, a total of 6 times, and blood was taken to measure the level of gonadal hormones before each sampling.
|
35 years old group
|
Subjects need to collect 5ml whole blood (EDTA or heparin anticoagulant) once in the morning on an empty stomach.
Endometrial tissue samples were taken during a complete 28-day menstrual cycle, a total of 6 times, and blood was taken to measure the level of gonadal hormones before each sampling.
|
42 years old group
|
Subjects need to collect 5ml whole blood (EDTA or heparin anticoagulant) once in the morning on an empty stomach.
Endometrial tissue samples were taken during a complete 28-day menstrual cycle, a total of 6 times, and blood was taken to measure the level of gonadal hormones before each sampling.
|
49 years old group
|
Subjects need to collect 5ml whole blood (EDTA or heparin anticoagulant) once in the morning on an empty stomach.
Endometrial tissue samples were taken during a complete 28-day menstrual cycle, a total of 6 times, and blood was taken to measure the level of gonadal hormones before each sampling.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Panorama of the endometrium
Time Frame: Menstrual cramps 24 hours, the seventh day of menstruation, LH peak, 72 hours after the peak, the 21st day of menstruation, the 28th day of menstruation
|
Discovery of inner membrane receptive proteins and pathways
|
Menstrual cramps 24 hours, the seventh day of menstruation, LH peak, 72 hours after the peak, the 21st day of menstruation, the 28th day of menstruation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MOM
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrium; Senility
-
Jagiellonian UniversityCompletedUterine Bleeding | Endometrium; Senility | Uterine PolypPoland
-
Sun Yat-sen UniversityUnknown
-
Fertigo Medical LtdKaplan Medical CenterCompleted
-
Aristotle University Of ThessalonikiCompleted
-
Ibn Sina HospitalGanna HospitalCompleted
-
Kaohsiung Veterans General Hospital.UnknownEndometrium | LaserTaiwan
-
Peking Union Medical College HospitalMerck Serono International SACompletedPostmenopausal EndometriumChina
-
Nanjing UniversityUnknown
-
Philipps University Marburg Medical CenterGerman Cancer AidRecruitingCancer of Endometrium Stage I | Cancer of Endometrium Stage IIJapan, Germany, Korea, Republic of
-
Eli Lilly and CompanyGynecologic Oncology GroupCompletedNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Uterine Neoplasms | Genital Neoplasms, Female | Endometrial Neoplasms | Endometrial Cancer | Endometrium Cancer | Cancer of Endometrium | Cancer of the Endometrium | Neoplasms, EndometrialUnited States
Clinical Trials on Endometrial biopsy
-
Jon HavelockTerminatedInfertility | PregnancyCanada
-
Cook Group IncorporatedTerminatedUterine Neoplasms | Polycystic Ovary Syndrome | Endometrial Neoplasms | MenorrhagiaPanama
-
Centre Hospitalier Universitaire de NīmesWithdrawnInfertility | Abortion, Spontaneous | Embryo Implantation, DelayedFrance
-
Clinique OvoActive, not recruiting
-
University of Sao PauloConselho Nacional de Desenvolvimento Científico e TecnológicoTerminated
-
McGill UniversityUnknown
-
Brown FertilityWithdrawnRecurrent Implantation Failure in Setting of Artifically Prepared Endometrium
-
Cairo UniversityUnknownRIF , Endometrial Receptivity
-
University of North Carolina, Chapel HillCompleted
-
Cairo UniversityUnknownEndometrial Receptivity and Success Rate of IVFEgypt